Special Drug Use Investigation for LAMICTAL Bipolar
NCT01428518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1036
Last updated 2016-04-25
Summary
This post-marketing surveillance study is designed to collect and assess information on safety and effectiveness of lamotrigine tablets in patients with bipolar disorder in routine clinical practice.
("LAMICTAL" is a trademark of the GlaxoSmithKline group of companies.)
Conditions
Interventions
- DRUG
-
Lamotrigine tablets
Administered according to the prescribing information in the locally approved label by the authorities.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
More Related Trials
-
Divalproex vs. Lamotrigine for Bipolar Disorder
NCT00451542 ·Status: TERMINATED
-
Bipolar Disorder Study for Men and Women
NCT00056277 ·Status: COMPLETED ·Phase: PHASE3
-
Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
NCT00513019 ·Status: COMPLETED ·Phase: PHASE2
-
Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
NCT00181844 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
NCT00579982 ·Status: COMPLETED ·Phase: PHASE3
-
Depression And Bipolar Disorder
NCT00274677 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression
NCT00475137 ·Status: COMPLETED ·Phase: PHASE2
-
Lamictal Bipolar Observational Study
NCT00460226 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects
NCT00907985 ·Status: TERMINATED ·Phase: PHASE1
-
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
NCT00360126 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
NCT00410371 ·Status: COMPLETED ·Phase: PHASE1
-
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581 ·Status: RECRUITING ·Phase: PHASE4
-
New Drugs in the Treatment of Mood Disorders
NCT00001482 ·Status: COMPLETED ·Phase: PHASE2
-
Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
NCT00280293 ·Status: COMPLETED ·Phase: PHASE4
-
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
NCT00223509 ·Status: COMPLETED ·Phase: PHASE4
-
Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania
NCT00206778 ·Status: COMPLETED ·Phase: PHASE2
-
Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder
NCT01864551 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
NCT00240721 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine Therapy in Geriatric Bipolar Depression
NCT00720473 ·Status: COMPLETED ·Phase: NA
-
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
NCT01015586 ·Status: COMPLETED ·Phase: PHASE4
-
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
NCT02989727 ·Status: COMPLETED ·Phase: PHASE4
-
Decision-Making in Bipolar Disorder
NCT01463111 ·Status: COMPLETED ·Phase: NA
-
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
NCT00723450 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
NCT00195845 ·Status: COMPLETED ·Phase: PHASE4
-
Lamotrigine for Symptoms of Geriatric Bipolar Depression
NCT00621842 ·Status: COMPLETED ·Phase: PHASE3